CHOP plus rituximab chemoimmunotherapy of indolent B-cell lymphoma.

Czuczman, M S

CHOP plus rituximab chemoimmunotherapy of indolent B-cell lymphoma. [electronic resource] - Seminars in oncology Oct 1999 - 88-96 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

0093-7754


Adult
Aged
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Murine-Derived
Antigens, CD20
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Cyclophosphamide--administration & dosage
Doxorubicin--administration & dosage
Female
Humans
Lymphoma, Non-Hodgkin--drug therapy
Male
Middle Aged
Pilot Projects
Prednisolone--administration & dosage
Remission Induction
Rituximab
Vincristine--administration & dosage